We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+21.1%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
–
AUM
$1.21B
AUM Growth
-$248M
Cap. Flow
-$400M
Cap. Flow %
-32.99%
Top 10 Hldgs %
23.94%
Holding
810
New
297
Increased
109
Reduced
151
Closed
223

Top Buys

Rank Stock Value
1
CZR icon
Caesars Entertainment
CZR
+$16.2M
2
ADPT icon
Adaptive Biotechnologies
ADPT
+$15.8M
3
TRIT
Triterras, Inc. Class A Ordinary Shares
TRIT
+$12.7M
4
NBL
Noble Energy, Inc.
NBL
+$11.9M
5
SLP icon
Simulations Plus
SLP
+$10.6M

Top Sells

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$16M
2
BLUE
bluebird bio
BLUE
+$12.2M
3
BHP icon
BHP
BHP
+$10.7M
4
ALLO icon
Allogene Therapeutics
ALLO
+$8.56M
5
WTW icon
Willis Towers Watson
WTW
+$6.59M

Sector Composition

Rank Sector Weight
1 Healthcare 13.03%
2 Technology 7.51%
3 Consumer Discretionary 5.23%
4 Financials 5.2%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRMY icon
551
Harmony Biosciences
HRMY
$2.04B
$206K 0.02%
+6,277
New +$229K
SLNO
552
DELISTED
Soleno Therapeutics
SLNO
$205K 0.02%
6,667
-2,860
-30% -$83.6K
DXCM icon
553
PUT
DexCom
DXCM
$27.6B
$204K 0.02%
2,000
-1,600
-44% -$167K
PPL
554
PUT
PPL Corp
PPL
$27.3B
$204K 0.02%
+7,500
New +$202K
JETS icon
555
US Global Jets ETF
JETS
$802M
$203K 0.02%
+11,825
New +$201K
RTX icon
556
RTX Corp
RTX
$287B
$203K 0.02%
3,500
-3,544
-50% -$216K
PMVP icon
557
PMV Pharmaceuticals
PMVP
$66.1M
$200K 0.02%
+5,000
New +$184K
UNVR
558
DELISTED
Univar Solutions Inc.
UNVR
$199K 0.02%
+11,700
New +$207K
MTCR
559
DELISTED
Metacrine, Inc. Common Stock
MTCR
$197K 0.02%
+19,246
New +$197K
LEAP.U
560
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
$195K 0.02%
+15,000
New +$191K
INBX
561
DELISTED
Inhibrx, Inc. Common Stock
INBX
$185K 0.02%
+10,421
New +$189K
AEG icon
562
Aegon
AEG
$13.5B
$180K 0.01%
+76,297
New +$203K
IMTXW
563
DELISTED
Immatics N.V. Warrants
IMTXW
$175K 0.01%
+50,000
New +$167K
SBBP
564
DELISTED
Strongbridge Biopharma plc.
SBBP
$173K 0.01%
+82,450
New +$278K
FEAC.WS
565
DELISTED
Flying Eagle Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A com
FEAC.WS
$172K 0.01%
+50,000
New +$180K
LCAPU
566
DELISTED
Lionheart Acquisition Corp. II Unit
LCAPU
$150K 0.01%
+15,000
New +$149K
BMY.RT
567
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$143K 0.01%
69,656
– –
CLOVW
568
DELISTED
Clover Health Investments, Corp. Warrants
CLOVW
$131K 0.01%
+33,333
New +$104K
JBLU icon
569
JetBlue
JBLU
$1.96B
$126K 0.01%
+10,815
New +$121K
APHA
570
DELISTED
Aphria Inc. Common Shares
APHA
$120K 0.01%
+26,900
New +$126K
JSPRW icon
571
Japer Therapeutics Warrants
JSPRW
$183K
$118K 0.01%
100,000
– –
CCAC.WS
572
DELISTED
CITIC Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary sh
CCAC.WS
$112K 0.01%
+100,000
New +$83.3K
AMST icon
573
Amesite
AMST
$5.79M
$111K 0.01%
+2,166
New +$123K
RNTX
574
Rein Therapeutics
RNTX
$67.7M
$106K 0.01%
4,250
+1,750
+70% +$41.2K
WATT icon
575
Energous
WATT
$80.3M
$101K 0.01%
+55
New +$108K
21 22
23
24 25

Similar funds

AUB
Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.22B AUM 17.11% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
MIM
Merewether Investment Management Dallas, Texas $5.16B AUM 86.81% 1-Year Est. Return
AAI
Aequim Alternative Investments Mill Valley, California $5.16B AUM 9.8% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Maven Securities's Q3 2020 Portfolio in Review

As of Q3 2020, Maven Securities held 810 positions worth $1.21B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Maven Securities withdrew a net $400M in Q3 2020, closing 223 positions and reducing 151 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Maven Securities opened a new position in Adaptive Biotechnologies worth $18M.

  • Maven Securities's largest Q3 2020 buy was Adaptive Biotechnologies: 375,000 shares worth $18M.
  • Maven Securities added most to Caesars Entertainment in Q3 2020, an estimated $16.2M increase.
  • Maven Securities's biggest Q3 2020 reduction was BHP, cutting an estimated $10.7M.
  • Maven Securities fully exited Agios Pharmaceuticals in Q3 2020, selling an estimated $16M.
  • Maven Securities's ten largest holdings make up 24% of its $1.21B portfolio in Q3 2020.
  • Maven Securities opened 297 new positions and closed 223 in Q3 2020.
  • Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.21B.

Based on Maven Securities's 13F filing for Q3 2020, filed 13 Nov 2020.